FDA issued a Warning Letter to Nostrum Laboratories Inc on 4/27/2009 for a later inspection.
483 Nostrum Labs Mar 2008

483 Nostrum Labs Mar 2008

Shirley Berryman FDA, Cynthia Goudeau FDA, Michele Obert FDA$119.00 - Available Now

FDA investigators audited the Nostrum Labs - Kansas City, MO, United States facility and issued inspectional observations (via FDA 483) on 11 Mar 2008.

Product details

  • Category: Human Drugs
  • Inspection end: 11 Mar 2008
  • Location: Kansas City, United States
  • FEI: 1930436
Add To Cart